ID: ALA4213176

Max Phase: Preclinical

Molecular Formula: C26H29N3O6

Molecular Weight: 479.53

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOC(=O)[C@@H]1CN(CCn2c(=O)[nH]c3ccccc3c2=O)CC[C@@H]1c1cccc2c1OCCO2

Standard InChI:  InChI=1S/C26H29N3O6/c1-2-33-25(31)20-16-28(11-10-17(20)18-7-5-9-22-23(18)35-15-14-34-22)12-13-29-24(30)19-6-3-4-8-21(19)27-26(29)32/h3-9,17,20H,2,10-16H2,1H3,(H,27,32)/t17-,20-/m1/s1

Standard InChI Key:  NNVKSALIQZOGHN-YLJYHZDGSA-N

Associated Targets(Human)

Synaptic vesicular amine transporter 118 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serotonin 2a (5-HT2a) receptor 14758 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dopamine transporter 10535 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serotonin 1a (5-HT1a) receptor 14969 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Synaptic vesicular amine transporter 20 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 479.53Molecular Weight (Monoisotopic): 479.2056AlogP: 2.13#Rotatable Bonds: 6
Polar Surface Area: 102.86Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.82CX Basic pKa: 7.59CX LogP: 3.30CX LogD: 2.90
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.54Np Likeness Score: -0.67

References

1. Provencher BA, Eshleman AJ, Johnson RA, Shi X, Kryatova O, Nelson J, Tian J, Gonzalez M, Meltzer PC, Janowsky A..  (2018)  Synthesis and Discovery of Arylpiperidinylquinazolines: New Inhibitors of the Vesicular Monoamine Transporter.,  61  (20): [PMID:30240563] [10.1021/acs.jmedchem.8b00542]

Source